Details

Last Funding Type

Series A

Last Funding Money Raised

¥250M

Industries

Biotechnology

Founded date

Feb 1, 2021

Number Of Employee

51 - 100

Operating Status

Active

PhaBuilder is a platform-based & product-based company with advanced technology in synthetic biology, focusing on the transformation and engineering application of halophilic microbes.

PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainly uses the cutting-edge "Next Generation Industrial Biotechnology(NGIB)" to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor.

PhaBuilder currently has two PHA plants under construction - the synthetic biology intelligent development plant in Beijing China-Germany Industrial Park and the 10 kt/annum plant in Yichang, Hubei Province. It also plans to build up 3-5 large-scale production bases throughout China within five years.

At present, PhaBuilder has completed two rounds of financing, raising around 300 million yuan in total. The investors include Sequoia Capital, China State-owned Enterprise Mixed Ownership Reform Fund, and GRC SinoGreen Fund, etc.

In the future, PhaBuilder will constantly promote synthetic biotechnology to deeply integrate with people's lives and upgrade the intelligent biological manufacturing industry, in order to achieve PhaBuilder's core mission of "Using microbes to change the world and build a green future".